Table 4.

Predictive performance of MG, radiomics signature, clinical features and the nomogram

Predictive Model	Metastatic ALN Predictive Performance
	Sensitivity	Specificity	Accuracy	AUC (95% CI)
MG-reported	42.7%	90.8%	24.1%	0.666 (0.591 to 0.741)
Radiomics signature	75.0%	77.1%	76.4%	0.862 (0.822 to 0.896)
Clinical features	45.8%	85.4%	72.2%	0.657 (0.590 to 0.708)
Radiomics nomogram*	75.0%	81.3%	79.2%	0.863 (0.821 to 0.897)

AUC, area under the curve; CI, confidence interval; MG, mammography.

Note: * represent for the model of radiomics signature +clinical features.